Abstract
Objective Fibromyalgia (FM) and insomnia frequently coexist, but whether FM is an independent causal risk factor for insomnia, and/or vice versa, remains unclear. We investigated the bidirectional causal relationship between FM and insomnia.
Methods Genome-wide association studies (GWAS) summary statistics on FM [sample size = 416,757 (2689 cases; 299,606 controls) (FinnGen)] and insomnia [sample size = 462,341 (UK Biobank)] were used. The possible causal relationships were assessed by bi-directional MR analysis. The major analysis method of MR was performed using inverse-variance weighted (IVW), supplemented by MR-Egger, weighted median, weighted mode and simple mode approaches. In addition, sensitivity analyses including Cochran’s Q test, MR-Egger intercept test, and the leave-one-out test were conducted to ensure the stability of the results.
Results There was strong evidence to suggest insomnia is a risk factor for FM (odds ratio (OR) 7.65, 95% confidence interval (CI) 3.17-18.45, p = 5.85E-06). We found no evidence that genetic liability to FM increases insomnia (OR = 1.00, 95% CI 0.99-1.01, p = 0.99)
Conclusions This study provides evidence in support of a causal relationship between insomnia and increased risk of FM, whilst overcoming the major limitations of previous epidemiological studies. Interventions for insomnia may be an effective strategy to prevent or reduce the burden of FM. Extended study needs to be performed with multi-center, large-scale GWAS cohort studies to re-evaluate the association between FM and insomnia in future.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding This work was supported by grants from National Natural Science Foundation of China (www.nsfc.gov.cn) (No. 30801025), Key Research and Development Plan of Shandong Province (No. 2016GSF201045, 2017GSF18150), Shandong Province medicine health development plan（2013WS0120）, Natural Science Foundation of Shandong Province（ZR2021MH286），Technology Foundation for Selected Overseas Chinese Scholar, Qingdao people's Livelihood Science and Technology Program (17-3-3-19-nsh，22-3-7-smjk-19-nsh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
